THC Heart-Rate Findings Reversed Direction Across Human and Animal Evidence in a Meta-Analysis
A 2018 meta-analysis found acute THC generally lowered heart rate in the analyzed animal groups while increasing it in the human evidence. The opposite directions illustrate why cardiovascular findings cannot be transferred across species without qualification.
The synthesis retained experimental conditions
Thirty-one studies met the review's criteria. The authors separated anesthetized animals, conscious animals and disease or stress models, alongside human data. Blood pressure, heart rate and blood flow were also distinct outcomes rather than one cardiovascular score.
The human estimate did not mirror the animal pattern
Acute human administration was associated with a pooled heart-rate increase, while the animal groups showed decreases under their respective conditions. This does not mean every human will show an increase or that every animal protocol produces a decrease. It describes the analyzed comparisons.
Blood-flow findings need their tissue context
The review included cerebral blood-flow observations in murine stroke models and large-artery findings under other conditions. These are not interchangeable with human brain perfusion or protection from a clinical stroke. Chronic and acute dosing also need separate reporting.
Interpreting the evidence
For a cardiovascular claim, identify species, anesthesia, disease state, exposure duration and measured variable. This review supports a conditional interpretation of THC's effects. It does not establish an individual's impairment, cardiovascular diagnosis or a safe exposure level.
Related reading: interpreting cannabis tolerance claims.
Research reference
Salahaden R. Sultan; Sophie A. Millar; Saoirse E. O’Sullivan; Timothy J. England (2018). A Systematic Review and Meta-Analysis of the In Vivo Haemodynamic Effects of Δ9-Tetrahydrocannabinol. Pharmaceuticals. doi:10.3390/ph11010013.
This analysis draws on the supplied review’s abstract and introductory material.
